Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year…
Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. WuXi AppTec excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with precision and scalability. "WuXi AppTec's integrated CRDMO platform continues to redefine what strategic partnership means in the pharmaceutical ecosystem," said Unmesh Lal, Vice President at Frost…
PR Newswire
20/11/2025
KLKB1 Inhibitors Market to Reach New Heights by 2034 Owing to the Launch of…
Key Takeaways from the KLKB1 Inhibitors Market Report Key Takeaways from the KLKB1 Inhibitors Market Report Discover which indication is expected to grab the major KLKB1 inhibitors market share @KLKB1 Inhibitors Market Report Key Factors Driving the KLKB1 Inhibitors Market Rising Prevalence of Hereditary Angioedema The increasing number of patients diagnosed with HAE, a rare genetic disorder that causes severe swelling attacks, is a primary driver. KLKB1 inhibitors...
PR Newswire
19/11/2025
Transactions with shares and linked securities in Genmab A/S made by managerial…
Company AnnouncementCOPENHAGEN, Denmark; November 19, 2025 –Genmab A/S(Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons.The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to...
Nasdaq GlobeNewswire
19/11/2025
Novartis announces plans to build flagship manufacturing hub in North Carolina
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic areas in one geographic locationMarks latest milestone in company’s previously announced $23 billion investment in US infrastructure Basel, November 19, 2025– Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina,...
Nasdaq GlobeNewswire
19/11/2025
NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey…
Long-tailed macaques are integral to biomedical research globally due to their close biological similarity to humans. Long-tailed macaques are the most commonly studied nonhuman primate species for drug safety assessment. Research with long-tailed macaques has been crucial for advances in regenerative medicine, immunology, cancer, vaccine development and pharmacology. Long-tailed macaques are integral to biomedical research globally due to their close biological similarity to humans....
PR Newswire
19/11/2025
IPSEN - Buy-back programme - Art 5 of MAR - Week 46 - 2025
Aggregated presentation by day and by marketStatement of transactions in own shares from November 10th to November 14th 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1110/11/2025FR0010259150 300 ...
Nasdaq GlobeNewswire
19/11/2025
Vascular Imaging Market worth US$4.54 billion by 2030 with 7.3% CAGR |…
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247188200 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247188200 Browse in-depth TOC on "Vascular Imaging Market" 320 - Tables 45 - Figures 323 - Pages By product,the global vascular imaging market is segmented into systems & consoles, accessories & consumables, and software & services. Systems and consoles account for the largest market share...
PR Newswire
19/11/2025
Compounding Chemotherapy Market to Reach $6.3 Billion by 2027 in the short run…
Request Sample of the Report on Compounding Chemotherapy Market Forecast 2034 – https://www.alliedmarketresearch.com/request-sample/A11418 Request Sample of the Report on Compounding Chemotherapy Market Forecast 2034 –https://www.alliedmarketresearch.com/request-sample/A11418 Market Introduction The compounding chemotherapy market involves the preparation of customized chemotherapy medications tailored to individual patient needs. This practice addresses specific requirements...
PR Newswire
19/11/2025
Cell Culture Media Market Outlook: Strong 13.2% CAGR to Drive $12.8 Billion…
Request a free sample copy of this report: Cell Culture Media Market Request a free sample copy of this report:Cell Culture Media Market Innovation in cell culture media also significantly supports the burgeoning field of advanced therapeutics. A notable development occurred inDecember 2024when Mesoblast received FDA approval for Ryoncil (remestemcel-L), marking it as the first and only mesenchymal stromal cell (MSC) therapy approved in the U.S. for treating steroid-refractory acute...
PR Newswire
19/11/2025
Hepatitis B and C Therapeutics Market Surges to US$17.02 Billion in 2024 as…
Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=hepatitis-b-and-c-therapeutics-market Buy This Report with Year-End Offer ( Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer):https://www.datamintelligence.com/buy-now-page?report=hepatitis-b-and-c-therapeutics-market Market Dynamics: Strong Push from Antiviral Innovation, Screening...
PR Newswire
19/11/2025
Dreamegg Unveils Sunrise Alarm Clocks -- Up to 42% Off for Winter Mornings and…
Leading this year's promotion is the Sunrise 1, offering the strongest discount of the event. Designed for users who prefer an easy, screen-free routine, it features intuitive button control, a soft sunrise simulation, relaxing white-noise options, and a warm glow that helps you wake naturally — even during the darkest winter weeks. Leading this year's promotion is theSunrise 1, offering the strongest discount of the event. Designed for users who prefer an easy, screen-free routine, it...
PR Newswire
19/11/2025
Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid…
Tsingke Biotech combines advanced gene synthesis, automated expression, and purification technologies to deliver rapid protein production. The company supports six expression systems—including E. coli, Bacillus subtilis, yeast, insect, mammalian, and cell-free systems—allowing simple proteins to be produced in 3 days via cell-free methods, while complex proteins and antibodies are ready in 7–14 days. According to Tsingke, overall protein expression success reaches 95%. Tsingke Biotech…
PR Newswire
19/11/2025
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging…
Amsterdam, the Netherlands –Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership withCortechs.ai, a pioneer in quantitative neuroimaging solutions. Together, the companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems [1], empowering clinicians with faster, more objective, and reproducible insights into brain health. The collaboration strengthens Philips’...
Nasdaq GlobeNewswire
19/11/2025
New Survey Reveals Ongoing Communication Barriers for Deaf and Hard-of-Hearing…
The majority of both Deaf participants (62%) and Hard-of-Hearing participants (66%) reported that communication barriers impacted their career decisions, limiting job opportunities and professional growth. The need to rely on regular assistance from hearing individuals in work-related communications remains a major obstacle for both groups, preventing them from fully participating or maximizing their potential in the workforce. The majority of both Deaf participants(62%)and Hard-of-Hearing...
PR Newswire
19/11/2025
Sapphiros announces a strategic agreement with Roche, providing Roche access to…
Under this partnership, Roche will also gain access to Sapphiros' future novel molecular multiplex technology. The single user step, instrument-free, connected, multiplex molecular platform will deliver affordable lab quality performance to point-of-care and home self-testing. Under this partnership, Roche will also gain access to Sapphiros' future novel molecular multiplex technology. The single user step, instrument-free, connected, multiplex molecular platform will deliver affordable lab...
PR Newswire
19/11/2025
Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry…
First cohort features 7 real-world challenges across R&D, manufacturing and supply chain, commercial and medical affairs Teva's first-ever global innovation platform aims to accelerate patient impact and drive business transformation, as part of its Pivot to Growth StrategyRise will enable startups and tech players worldwide to validate their solutions in real-world settings, scaling impact across Teva's global ecosystem including in the U.S., Europe, Israel and beyondTEL...
Nasdaq GlobeNewswire
19/11/2025
GUERBET : Financial agenda for 2026
Financial agenda for 2026Villepinte, November 19, 2025:Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2026. Publications calendar 2025 ANNUAL REVENUE February 05, 2026,after trading2025 ANNUAL RESULTSMarch 11, 2026, after trading2026 1ST QUARTER REVENUE April 23, 2026,after tradingANNUAL SHAREHOLDERS’ MEETING May 22, 2026 2026 2ND QUARTER...
Nasdaq GlobeNewswire
19/11/2025
Curium Announces First Commercial Doses of Diagnostic Radiopharmaceutical in…
Curium has entered a partnership with the Czech company ÚJV Řež, a leading expert in the development and production of radiopharmaceuticals, to manufacture diagnostic radiopharmaceuticals for patients with prostate cancer in both Czech Republic and Slovakia This will provide solutions to a wider patient group across both countries where there is high demand and unmet needPARIS, Nov.19, 2025(GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, has announced that patients...
Nasdaq GlobeNewswire
19/11/2025
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing…
Gene editing of HSPCs offers the potential for long-term therapeutic benefit. While viral vectors such as AAV6 are commonly used for gene insertion, they raise safety and efficacy concerns. Over the past decade, non-viral DNA templates delivery has emerged as promising alternatives and have been used with nucleases to target short single-stranded linear DNA corrective template in HSPCs. Although non-viral approaches were initially limited to making only small corrections within defective...
Nasdaq GlobeNewswire
19/11/2025
One Device for Your Essential Home Inspection Needs -- Raythink's EX10 Launches…
A Tool Designed for Essential Home Inspection Need A Tool Designed for EssentialHome Inspection Need The EX10 offers fast, contact-free, precise inspections. Its infrared imager highlights temperature differences, identifies hidden defects, and supports in-depth analysis across home inspection scenarios: Winter: The Optimal Season for Home Inspection Winter is the ideal time for a home inspection. The contrast between indoor heating and cold outdoor temperatures makes issues...
PR Newswire
19/11/2025
KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer…
Compact Footprint and Workflow Efficiency Compact Footprint and Workflow Efficiency Despite its small 0.36 m² footprint, the Polaris V150 delivers 150 tests per hour, enabling laboratories to achieve high operational efficiency within limited workspace. It supports continuous loading of samples, reagents, and reaction cups, while its STAT function ensures urgent samples are prioritized for rapid clinical decision-making. The system offers 40 sample positions, accommodates serum and plasma,...
PR Newswire
19/11/2025
European study shows falling prices, rising costs and shortages - findings from…
In the context of AMR Awareness Week, Viatris Inc. (Nasdaq: VTRS), a global healthcare company, with Medicines for Europe – the voice of the generic, biosimilar, and value-added medicines industries in Europe – present findings from a from an independent study by New Angle, a consulting and research agency, investigating the reasons behind shortages of essential off-patent medicines, with a particular focus on antibiotics. In the context of AMR Awareness Week,Viatris Inc. (Nasdaq: VTRS), a...
PR Newswire
19/11/2025
Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives…
As Piramal Pharma Solutions' dedicated antibody-drug conjugate (ADC) development and manufacturing facility, Grangemouth offers comprehensive solutions for bioconjugates, from process development to scale-up. The site also plays a critical role in the ADCelerate™ program, which streamlines the path from R&D to GMP production to bring lifesaving bioconjugate therapies to patients in the clinic faster. As Piramal Pharma Solutions' dedicated antibody-drug conjugate (ADC) development and...
PR Newswire
19/11/2025
Essity awarded EcoVadis Platinum medal for outstanding sustainability leadership…
EcoVadis' rigorous methodology rewards not only strong policies but also measurable actions and results. For Essity's key focus areas affecting its business, the sustainability rating reflects comprehensive policies on all key areas, including disclosure on progress toward the UN Sustainable Development Goals (SDGs). EcoVadis' rigorous methodology rewards not only strong policies but also measurable actions and results. For Essity's key focus areas affecting its business, the sustainability...
PR Newswire
19/11/2025
Altri Comunicati